Clinical Trials Logo

Clinical Trial Summary

Iron depletion is common in female athletes depending on the sports discipline. Endurance and resistance exercise can induce inflammation thereby reducing dietary iron absorption. Galacto-oligosaccharides (GOS) improved iron absorption in young healthy women and infants, and improved gut inflammation in iron-supplemented infants. A stable isotope study will be performed to investigate the effect exercise and acute and chronic GOS supplementation on inflammation and iron absorption in female athletes.


Clinical Trial Description

Iron depletion is common in athletes, particularly in females, reaching prevalence rates up to 70% depending on the sports discipline. As iron is essential for energy production and oxygen transport, a deficiency can impair performance, especially in endurance athletes. Iron deficiency in athletes may be caused by inadequate intake, but reduced iron absorption and increased losses also seem to play a role. Both endurance and resistance exercise at a high intensity, can induce inflammation resulting in a hepcidin response via interleukin-6 (IL-6) regulation. Hepcidin is the master regulator of systemic iron homeostasis, and a recent study in adult males showed that vigorous exercise decreases dietary iron absorption associated with increases in IL-6 and hepcidin. Iron losses induced by exercise have been attributed to several factors, including gastrointestinal bleeding associated with endothelial damage, haematuria, haemolysis, and increased sweating. Galacto-oligosaccharides (GOS) have been shown to acutely enhance iron absorption in young, healthy women. In Kenyan infants with a high infectious disease burden, chronic GOS administration improved iron absorption and mitigated the negative effects of iron supplementation on gut inflammation, likely mediated by its bifidogenic effect. Whether GOS has the potential of improving iron absorption has not been studied in athletes. The study aims are to determine 1) the effects of a bout of resistance exercise at 70% 1 repetition maximum (RM) on inflammation, hepcidin and iron absorption in high performance female team athletes; and 2) the effect of acute and chronic GOS supplementation on iron absorption in response to the exercise bout. The trial will entail two series of three iron absorption conditions separated by six weeks of GOS supplementation (10 g/day). The study participants will be 22 female university athletes recruited from the hockey, soccer and netball teams of North-West University, Potchefstroom, South Africa. At baseline, the first series of three iron absorption studies will be conducted, all measuring iron absorption from a supplement administered with labelled ferrous fumarate in the following conditions: 1) after a period of rest; 2) three hours after an acute resistance exercise bout; and 3) three hours after an acute resistance exercise bout, co-administered with GOS. Following this, participants will consume GOS daily for six weeks, followed by an identical series of iron absorption studies. Markers of systemic and gut inflammation, hepcidin, microflora composition and iron status indicators before and after the GOS intervention will be determined. In addition, erythrocyte iron incorporation will be determined after both series of isotope studies. Furthermore, the kinetics of isotope appearance, inflammatory markers, and hepcidin for 24 hours during each of the six iron absorption studies will be investigated. The primary hypotheses are that fractional iron absorption from a supplemental dose of ferrous fumarate will be: 1) lower three hours post exercise than post resting period; 2) higher with co-administration of GOS than without, both before and after six-week GOS intervention; and 3) higher after six-week intervention with GOS compared to baseline. The secondary hypotheses are: 1) acute exercise bout will result in increased inflammatory and hepcidin response before and after intervention with GOS but the intervention may mediate these two responses; 2) chronic GOS intervention will increase relative abundance of Bifidobacterium spp, reduce gut inflammation and improve gut integrity and gut health; 3) chronic GOS intervention will improve iron status. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06038656
Study type Interventional
Source North-West University, South Africa
Contact Linda Malan
Phone +27182994237
Email Linda.Malan@nwu.ac.za
Status Recruiting
Phase N/A
Start date March 1, 2024
Completion date November 30, 2024

See also
  Status Clinical Trial Phase
Terminated NCT03440879 - Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose N/A
Not yet recruiting NCT05936424 - Menstrual Cycle Phase Based Training N/A
Completed NCT05580263 - Different Order of Concurrent Training on Improving Visceral Adipose Tissue and Insulin Resistance. N/A
Recruiting NCT05574205 - Dietary Protein Quality for Skeletal Muscle Anabolism in Older Adults N/A
Recruiting NCT05482178 - The Association of Resistance Exercise With the Inflammasome Activation in Obesity Subjects N/A
Active, not recruiting NCT05347667 - Menstrual Cycle Phase Muscle Protein Synthesis N/A
Recruiting NCT05422300 - A 'Non-Invasive' Breath Test to Determine Anabolic Sensitivity in Females N/A
Not yet recruiting NCT06205147 - Effects of Elastic Band Resistance Exercise on Muscle Strength and Depression in Hospitalized Elderly. N/A
Recruiting NCT06209424 - Modified Breath Test to Determine Anabolic Sensitivity Across Physical Activity States N/A
Completed NCT05014035 - Feasibility of a Hybrid Delivery of Home-based Cluster Set Resistance Training in Lung Cancer N/A
Completed NCT04887883 - Influence of Sex and Training on de Novo Muscle Protein Synthesis
Enrolling by invitation NCT05110092 - Breathing-based Leg Resistance Exercise Improves Wound Healing, Blood Sugar and Quality of Life for Diabetic Foot Ulcers N/A
Completed NCT04028726 - Skeletal Muscle Protein Synthesis: Traditional and Cluster Sets N/A
Completed NCT04000893 - Effect of Aerobic or Resistance Exercise on the Endothelial Response in Post-acute Myocardial Infarction Patients Submitted to Angioplasty N/A